Loading company details...
Beta
Latest Form 4 (Oct 7, 2026): George M. Milne Jr. (Director): Sale of 30,000 shares, $830.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | George M. Milne Jr. | Sale | 30,000 | $830.9K |
| Sep 14, 2026 | Camille L. Bedrosian, Chief Medical Officer | Sale | 7,947 | $256.0K |
| Sep 14, 2026 | James M. Frates, Chief Financial Officer | Sale | 9,768 | $315.2K |
| Sep 14, 2026 | Gina Mazzariello, Chief Legal Officer | Sale | 9,525 | $309.1K |
| Sep 14, 2026 | Justin B. Klee, Co-Chief Executive Officer | Sale | 29,025 | $932.6K |
| Sep 14, 2026 | Joshua B. Cohen, Co-Chief Executive Officer | Sale | 29,545 | $950.0K |
| Sep 2, 2026 | Karen Firestone | Exercise/Conversion | 25,000 | $44.0K |
| Aug 21, 2026 | James M. Frates, Chief Financial Officer | Grant/Award | 22,807 | n/a |
| Aug 21, 2026 | Justin B. Klee, Co-Chief Executive Officer | Grant/Award | 60,039 | n/a |
| Aug 21, 2026 | Gina Mazzariello, Chief Legal Officer | Grant/Award | 21,284 | n/a |